Investor sentiment remains focused on profitability and valuation as higher interest rates continue to shape stock selection. In his latest lightning round, Jim Cramer says McKesson stands out as ...
Cardinal Health gains on Thursday after extending a key distribution relationship with CVS Health, easing a major uncertainty for investors as markets navigate higher Treasury yields and shifting ...
McKesson (MCK) stock is trading at $867.49, up 3.43% on the day, closing near the session high on moderate volatility. The stock is positioned above its key short-, ...
McKesson Corporation (MCK) dropped 3.64% after initial gains, even as strong fiscal first-quarter results and a raised guidance provided a fundamentally positive backdrop. The reversal is ...
McKesson (MCK) stock is trading at $858.15, marking a daily gain of 3.34%. The price sits above its key short- and long-term moving averages but remains under pressure ...
McKesson Corporation (MCK) dropped 3.44% today after CEO Brian S. Tyler sold 8,463 shares under a preset plan, with the move contradicting persistent signals of bullish momentum from technical ...
McKesson Corporation (MCK) stock is trading at $765.11, up 2.72% on the day. The price sits above its short-term moving averages but remains capped by longer-term trend ...
McKesson Corporation (MCK) climbed 2.43% after reporting robust free cash flow, fueling optimism about growth investment and capital returns. The rebound looks limited, with the stock still ...